Larry D Anderson Selected Research

Larry D Anderson Research Topics

Disease

41	Multiple Myeloma 04/2024 - 07/2011
7	Neoplasms (Cancer) 04/2024 - 10/2009
4	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 11/2020
3	Cytokine Release Syndrome 05/2024 - 01/2022
3	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 01/2022
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
2	Infections 05/2024 - 07/2023
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 01/2022
2	Disease Progression 01/2022 - 01/2022
2	Lymphoma (Lymphomas) 11/2020 - 01/2018
2	Meningoencephalitis 01/2013 - 08/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 08/2011
1	Cytopenia 05/2024
1	cell-associated neurotoxicity 05/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 05/2024
1	Paraproteinemias (Monoclonal Gammopathy) 02/2024
1	Monoclonal Gammopathy of Undetermined Significance 02/2024
1	Plasma Cell Leukemia 10/2023
1	COVID-19 07/2023
1	Amyloidosis 01/2023
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2023
1	POEMS Syndrome (Syndrome, POEMS) 12/2022
1	Thrombosis (Thrombus) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Pain (Aches) 10/2021
1	Leukemia 05/2021
1	Frailty 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Fatigue 11/2020
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Residual Neoplasm 11/2020
1	Disease Susceptibility (Diathesis) 07/2019
1	Hemorrhage 07/2019
1	Necrosis 12/2018
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018
1	Testicular Neoplasms (Testicular Cancer) 07/2011
1	Acute Promyelocytic Leukemia 06/2011

Drug/Important Bio-Agent (IBA)

19	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2018
18	Bortezomib (Velcade)FDA Link 04/2024 - 11/2018
15	Lenalidomide (CC 5013)FDA Link 04/2024 - 01/2020
9	daratumumabIBA 04/2024 - 01/2020
8	idecabtagene vicleucelIBA 10/2023 - 01/2021
7	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 12/2018
7	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2021
6	B-Cell Maturation AntigenIBA 12/2023 - 12/2018
6	Proteasome InhibitorsIBA 10/2023 - 12/2018
5	selinexorIBA 10/2021 - 11/2020
5	AntigensIBA 07/2019 - 10/2009
3	carfilzomibIBA 01/2022 - 11/2018
3	ibrutinibIBA 08/2020 - 01/2018
3	Peptides (Polypeptides)IBA 01/2013 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2023
2	Ferritins (Ferritin)IBA 10/2023 - 10/2023
2	pomalidomideIBA 01/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 08/2011
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	Immunoglobulin D (IgD)IBA 02/2024
1	C-Reactive ProteinIBA 10/2023
1	Neutralizing AntibodiesIBA 07/2023
1	COVID-19 VaccinesIBA 04/2023
1	VaccinesIBA 04/2023
1	Immunoglobulin G (IgG)IBA 04/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023
1	vinyltriethoxysilane (VTES)IBA 11/2022
1	tisagenlecleucelIBA 01/2022
1	axicabtagene ciloleucelIBA 01/2022
1	elotuzumabIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	ImidesIBA 01/2022
1	Exportin 1 ProteinIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 07/2019
1	Immunologic Factors (Immunomodulators)IBA 12/2018
1	Immunoconjugates (Immunoconjugate)IBA 12/2018
1	Cell Surface ReceptorsIBA 12/2018
1	monomethylauristatin FIBA 12/2018
1	belantamab mafodotinIBA 12/2018
1	Alkylating AgentsIBA 12/2018
1	AN-1792IBA 01/2013
1	DNA VaccinesIBA 01/2013
1	Amyloid beta-PeptidesIBA 08/2011
1	EpitopesIBA 07/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2011

Therapy/Procedure

32	Therapeutics 05/2024 - 10/2009
8	Stem Cell Transplantation 10/2023 - 07/2011
4	Transplantation 10/2023 - 01/2022
3	Immunotherapy 05/2024 - 08/2011
3	Cell Transplantation 12/2022 - 10/2009
2	Drug Therapy (Chemotherapy) 07/2023 - 11/2020
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Autologous Transplantation 01/2023
1	Hematopoietic Stem Cell Mobilization 01/2023